OTCMKTS:AUGX Augmedix (AUGX) Stock Price, News & Analysis $2.31 0.00 (0.00%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$2.31▼$2.3250-Day Range$0.89▼$2.3252-Week Range$0.73▼$6.25Volume121,382 shsAverage Volume692,605 shsMarket Capitalization$113.12 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsStock AnalysisChartEarningsFinancialsHeadlinesInsider TradesSEC Filings Get Augmedix alerts: Email Address Ad Porter & CompanyThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.So go here now to read my new report The Big AI Die-Up… while you still can. About Augmedix Stock (OTCMKTS:AUGX)Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.Read More AUGX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AUGX Stock News HeadlinesJuly 23, 2024 | msn.comLake Street Downgrades Augmedix (AUGX)July 22, 2024 | stockhouse.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Augmedix, Inc. BuyoutSeptember 7, 2024 | Deal Maker (Ad)The solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.July 19, 2024 | marketwatch.comAugmedix Agrees to $139 Million Acquisition by CommureJuly 19, 2024 | tmcnet.comAUGX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Augmedix, Inc. Is Fair to ShareholdersJuly 19, 2024 | msn.comAI-Focused Healthcare Documentation Provider Augmedix Goes Private In $139M DealJuly 19, 2024 | msn.comAugmedix to be acquired by Commure in transaction valuing the former at ~$139MJuly 15, 2024 | insidermonkey.comWhy Is Augmedix, Inc. (AUGX) the Best Penny Stock to Buy Under $1?September 7, 2024 | Deal Maker (Ad)The solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.May 21, 2024 | finance.yahoo.comRevenue Downgrade: Here's What Analysts Forecast For Augmedix, Inc. (NASDAQ:AUGX)May 14, 2024 | markets.businessinsider.comHold Rating on Augmedix Amidst Growth Deceleration and Market ChallengesMay 14, 2024 | markets.businessinsider.comLake Street Keeps Their Buy Rating on Augmedix (AUGX)May 14, 2024 | msn.comAugmedix crashes as Evercore downgrades after guidance cutMay 13, 2024 | investorplace.comAUGX Stock Earnings: Augmedix Beats EPS, Beats Revenue for Q1 2024April 25, 2024 | finance.yahoo.comAugmedix Awarded on Newsweek’s World’s Best Digital Health Companies 2024 ListApril 10, 2024 | finance.yahoo.comAugmedix Inc (AUGX) Chief Strategy Officer Ian Shakil Sells 89,167 SharesApril 4, 2024 | uk.finance.yahoo.comAugmedix Inc (AUGX) Chief Strategy Officer Ian Shakil Sells 97,441 SharesApril 4, 2024 | finanznachrichten.deAugmedix Inc: Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems NationwideSee More Headlines Receive AUGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Augmedix and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/12/2024Today9/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Health Information Services Sub-IndustryBusiness Services Current SymbolOTCMKTS:AUGX CUSIPN/A CIK1769804 Webwww.augmedix.com Phone888-669-4885FaxN/AEmployees710Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.43) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-24,450,000.00 Net Margins-57.70% Pretax Margin-57.23% Return on Equity-980.09% Return on Assets-57.85% Debt Debt-to-Equity Ratio3.74 Current Ratio1.70 Quick Ratio1.70 Sales & Book Value Annual Sales$51.58 million Price / Sales2.19 Cash FlowN/A Price / Cash FlowN/A Book Value$0.10 per share Price / Book23.10Miscellaneous Outstanding Shares48,968,000Free Float36,316,000Market Cap$113.12 million OptionableNot Optionable Beta-0.22 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Emmanuel Krakaris (Age 65)President, CEO, Secretary & Director Comp: $814.62kMr. Ian Shakil (Age 40)Founder, Chief Strategy Officer & Director Comp: $375.92kMs. Sandra Breber (Age 66)Chief Operating Officer Comp: $577.96kMr. Paul Louis Ginocchio (Age 54)Chief Financial Officer Mr. Saurav Chatterjee Ph.D. (Age 52)Chief Technology Officer Comp: $438.05kMr. Todd HolvickHead of Legal & ComplianceMs. Lia WallickHead of PeopleDr. Davin Lundquist M.D.Chief Medical OfficerMr. Jonathan Hawkins (Age 54)Chief Revenue Officer Comp: $417.71kMr. Tomer Levy (Age 50)Senior Vice President of Engineering More ExecutivesKey CompetitorsEntrepreneur Universe Bright GroupOTCMKTS:EUBGGravityNASDAQ:GRVYBowman Consulting GroupNASDAQ:BWMNMaxCyteNASDAQ:MXCTPriority TechnologyNASDAQ:PRTHView All Competitors AUGX Stock Analysis - Frequently Asked Questions How have AUGX shares performed this year? Augmedix's stock was trading at $5.85 at the beginning of the year. Since then, AUGX stock has decreased by 60.5% and is now trading at $2.31. View the best growth stocks for 2024 here. How were Augmedix's earnings last quarter? Augmedix, Inc. (OTCMKTS:AUGX) issued its earnings results on Monday, August, 12th. The company reported ($0.16) earnings per share for the quarter, missing analysts' consensus estimates of ($0.12) by $0.04. The company earned $13.66 million during the quarter, compared to analyst estimates of $13.68 million. Augmedix had a negative net margin of 57.70% and a negative trailing twelve-month return on equity of 980.09%. How do I buy shares of Augmedix? Shares of AUGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:AUGX) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Augmedix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Augmedix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
